Timosaponin B-II Inhibits Pro-Inflammatory Cytokine Induction by Lipopolysaccharide in BV2 Cells

Wen-Quan Lu,Yan Qiu,Tie-Jun Li,Xia Tao,Lian-Na Sun,Wan-Sheng Chen
DOI: https://doi.org/10.1007/s12272-009-1916-4
2009-01-01
Archives of Pharmacal Research
Abstract:It was reported that the total polysaccharides extracts from Anemarrhenae asphodeloides Bge (Liliaceae, rhizome) could inhibit inflammatory responses in various models. In the present study, the effects of Timosaponin B-II, a purified extract from A. asphodeloidesb, on the expressions of IL-1β, TNF-α and IL-6, the activity of NF-κB and the activation of signal pathway related to NF-κB were explored in vitro. Timosaponin B-II significantly attenuated increase of these cytokines on both mRNA and protein levels from LPS-stimulated BV2 cells in a dose-dependent manner. The reporter gene assay also showed that the activation of NF-κB induced by LPS was inhibited by pre-treatment with Timosaponin B-II. Moreover, western blot results showed that the activation of p38, JNK and P65 had been decreased. These results suggest that both NF-κB signal pathway and MAPK pathway were involved in the inhibitory effects of Timosaponin B-II on the expression of pro-inflammatory cytokines.
What problem does this paper attempt to address?